Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

9.36
Delayed Data
As of Feb 05
 -0.32 / -3.31%
Today’s Change
8.97
Today|||52-Week Range
22.66
-24.46%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close9.68
Today’s open9.55
Day’s range9.02 - 9.67
Volume123,513
Average volume (3 months)151,260
Market cap$274.8M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-120.60%
Earnings growth (this year)+31.87%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.36

Competitors

 Today’s
change
Today’s
% change
VTLVital Therapies Inc-0.05-0.54%
OMEDOncoMed Pharmaceutic...-0.20-2.10%
INFIInfinity Pharmaceuti...-0.26-4.35%
AKBAAkebia Therapeutics ...-0.27-3.50%
Data as of 4:14pm ET, 02/05/2016

Financials

Next reporting dateFebruary 12, 2016
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$0.00
Annual profit (last year)-$57.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers